Core D3: Synthetic Antigen Binder Generation & Crystallography
Core D3: Synthetic Antigen Binder Generation & Crystallography
批准号:
7922836
负责人:
SHOHEI KOIDE
金额:
$50.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2015-03-31
关键词:
AffinityAntibodiesArtsBacteriaBindingCell surfaceCommunitiesComplexCrystallizationCrystallographyDetergentsEngineeringEnvironmentFab ImmunoglobulinsFigs - dietaryFruitFunctional RNAFutureGenerationsGoalsLibrariesLocationMembrane ProteinsMethodologyMethodsModificationMolecular ChaperonesMolecular ConformationMonoclonal AntibodiesOutcomePerformancePhage DisplayPopulationPreparationPropertyProtein ConformationProtein DynamicsProtein EngineeringProtein Structure InitiativeProteinsReagentRecombinantsResearchResearch InfrastructureResourcesSamplingServicesShapesSideSiteSorting - Cell MovementSpecificityStructureSynthetic AntigensSystemTechnologyUnited States National Institutes of HealthWaterWorkXenopus oocytebasecombinatorialdesignflexibilityimprovedmembernovelnovel strategiesoverexpressionprotein complexprotein functionprotein purificationstructural biologytool
中文摘要
合成抗原结合剂“Sab Core”的总体目标是提供广泛的强大方法和新型试剂,以支持该联盟的研究目标。Sab Core具有独特的能力,基于在NIH蛋白质结构倡议(PSI)的支持下开发的专业知识和资源,以高通量的方式合成抗原结合物,可用于广泛的靶标,包括可溶性蛋白,蛋白质复合物,膜蛋白和功能性
英文摘要
The overarching goal of the Synthetic Antigen Binder "Sab Core" is to provide a broad range of powerful approaches and novel reagents to support the consortium's research objectives. The Sab Core is uniquely capable, based on the expertise and resources that have been developed under the auspices of the NIH Protein Structure Initiative (PSI), to generate in a high-throughput way synthetic antigen binders to an extensive range of targets including soluble proteins, protein complexes, membrane proteins and functional
RNA. Thus, the infrastructure in place with extensive capability to efficiently generate high-quality affinity reagents will dramatically accelerate membrane protein research performed within the MPSD Consortium, as well as in the entire membrane protein research community.
Our previous efforts had focused on generating Sabs for use as "crystallization chaperones" (1). This endeavor has led to the crystallization and structure determination of several high-hanging fruit systems.
Importantly, the Sab technology has a number of additional attributes that our team plans to exploit to investigate structure-dynamics-function relationships of membrane proteins in unique ways. Membrane proteins are dynamic machines that need to change their shape to perform their function. Therefore, it is critically important to functionally and structurally characterize major conformational states and determine how
their populations are modulated during the course of action.
Our Sabs are often exquisitely conformation-specific, making them
powerful probes for studying protein conformation dynamics. They can be used to
"lock" a protein in a specific conformational state, which allows for unequivocal
annotation of functional states (Fig. D3.1). Sabs can stabilize a specific
conformational state to facilitate structural determination. They can also be
engineered for use as affinity reagents to aid membrane protein purification as well
as to stabilize membrane protein targets for storage. The importance of the last
attribute cannot be overstated. Membrane proteins are inherently fragile. Since the
proposed projects in the MPSD Consortium often involve shipment of samples
between different locations, it is essential that they be delivered and stored in their
native states. Further, Sabs can be used to attach spectroscopic probes to a
specific location within a target with minimal modification to the target.
The Sab Core produces three distinct classes of Sabs, in the forms of the antigen-binding fragment (Fab) of antibodies and other designer proteins that collectively fulfill diverse needs in membrane protein research. These Sabs are generated from high-performance phage-display libraries that are designed based
on revolutionary concepts in protein engineering, and Sabs are produced in bacteria. It is our contention that, in the near future. Sabs will replace the traditional monoclonal antibody technology that is slow and expensive.
The goals of the Sab Core are (i) to provide high-quality synthetic affinity reagents for membrane protein targets using state-of-the-art technologies, (ii) to accelerate structure determination by Sab-based chaperone-assisted crystallography and (iii) to develop novel applications of Sabs that will enable Core users to significantly elevate the level of mechanistic understanding of membrane protein functions. Sabs generated
in this Core and ultimately the technology to produce Sabs will be made available to the broader scientific community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel biologics platform for targeting tumors driven by intracellular oncoproteins
-
批准号:10356663
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2021
-
负责人:SHOHEI KOIDE
-
依托单位:
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms
-
批准号:10344321
-
项目类别:
-
资助金额:$74.35万
-
财政年份:2021
-
负责人:SHOHEI KOIDE
-
依托单位:
Novel biologics platform for targeting tumors driven by intracellular oncoproteins
-
批准号:10533364
-
项目类别:
-
资助金额:$23.3万
-
财政年份:2021
-
负责人:SHOHEI KOIDE
-
依托单位:
Transport Mechanisms and Inhibition of Efflux Pumps in Pathogenic Organisms
-
批准号:10531273
-
项目类别:
-
资助金额:$74.35万
-
财政年份:2021
-
负责人:SHOHEI KOIDE
-
依托单位:
Accurate prediction of neutralization capacity from deep mining of SARS-CoV-2 serology
-
批准号:10195613
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2020
-
负责人:SHOHEI KOIDE
-
依托单位:
Probing RAS-mediated signaling mechanisms with monobody inhibitors
-
批准号:9977135
-
项目类别:
-
资助金额:$55.1万
-
财政年份:2018
-
负责人:SHOHEI KOIDE
-
依托单位:
Probing RAS-mediated signaling mechanisms with monobody inhibitors
-
批准号:10220892
-
项目类别:
-
资助金额:$55.1万
-
财政年份:2018
-
负责人:SHOHEI KOIDE
-
依托单位:
Probing RAS-mediated signaling mechanisms with monobody inhibitors
-
批准号:9751810
-
项目类别:
-
资助金额:$53.45万
-
财政年份:2018
-
负责人:SHOHEI KOIDE
-
依托单位:
Probing RAS-mediated signaling mechanisms with monobody inhibitors
-
批准号:9384266
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2017
-
负责人:SHOHEI KOIDE
-
依托单位:
Probing RAS-mediated Signaling with Monobody Inhibitors
-
批准号:10530818
-
项目类别:
-
资助金额:$60.15万
-
财政年份:2017
-
负责人:SHOHEI KOIDE
-
依托单位:
Probing RAS-mediated Signaling with Monobody Inhibitors
-
批准号:10666670
-
项目类别:
-
资助金额:$57.7万
-
财政年份:2017
-
负责人:SHOHEI KOIDE
-
依托单位:
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins
-
批准号:9889907
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2016
-
负责人:SHOHEI KOIDE
-
依托单位:
Molecular mechanisms of SHP2 signaling dissected with designer binding proteins
-
批准号:9028914
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2016
-
负责人:SHOHEI KOIDE
-
依托单位:
Genetically encoded designer inhibitors for functional epigenomics
-
批准号:8858611
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2013
-
负责人:SHOHEI KOIDE
-
依托单位:
Genetically encoded designer inhibitors for functional epigenomics
-
批准号:8642438
-
项目类别:
-
资助金额:$41.29万
-
财政年份:2013
-
负责人:SHOHEI KOIDE
-
依托单位:
SYNTHETIC BINDING PROTEINS
-
批准号:8361633
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2011
-
负责人:SHOHEI KOIDE
-
依托单位:
Renewable synthetic antibodies for epigenomics
-
批准号:7936835
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:SHOHEI KOIDE
-
依托单位:
Rational generation of directed protein-capture reagents
-
批准号:8539025
-
项目类别:
-
资助金额:$49.48万
-
财政年份:2009
-
负责人:SHOHEI KOIDE
-
依托单位:
Renewable synthetic antibodies for epigenomics
-
批准号:7815889
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:SHOHEI KOIDE
-
依托单位:
Rational generation of directed protein-capture reagents
-
批准号:7944024
-
项目类别:
-
资助金额:$50.3万
-
财政年份:2009
-
负责人:SHOHEI KOIDE
-
依托单位:
海外基金